Revelation Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Revelation Biosciences's balance sheet done over the years? Its assets were worth $12,212,609 last year, which is more than in the previous period. 46% of Revelation Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $5,564,894, which means an increase by 25% compared compared to last year.

Debt to Assets

Revelation Biosciences, Inc. (NASDAQ:REVBW): Debt to assets
2019 22671 26.30K 116.05%
2020 4620400 1.20M 26.16%
2021 2042212 2.14M 104.87%
2022 5503415 4.45M 80.88%
2023 12212609 5.56M 45.57%

REVBW Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
11.99M5.25M1.27M4.49M0
Short term investments
000525.28K0
Net receivables
00000
Inventory
00000
Other current assets
155.82K73.13K637.34K128K0
Total current assets
12.14M5.41M1.91M4.62M0
Non-current assets:
Property, Plant and Equipment
65.08K90.13K130.14K00
Goodwill
00000
Intangible assets
00000
Long term investments
00073.51M0
Other non-current assets
005022.67K
Total non-current assets
65.08K90.13K130.14K73.51M22.67K
Total assets
12.21M5.50M2.04M4.62M22.67K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
02.91M000
Short term debt
0-2.91M16.75K00
Total current liabilities
5.56M4.45M2.14M1.20M26.30K
Non-current liabilities:
Long term debt
00000
Deferred tax
00000
Other non-current liabilities
0554.20K2.91M2.91M0
Total non-current liabilities
0554.20K2.91M2.91M0
Total liabilities
5.56M4.45M2.14M1.20M26.30K
Data sourceData sourceData sourceData source